{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T10:32:51Z","timestamp":1794997971085,"version":"4.9.1"},"reference-count":25,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,1,7]],"date-time":"2009-01-07T00:00:00Z","timestamp":1231286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:p>\n                    <jats:bold>Background:\u2002<\/jats:bold>\n                    Chronic idiopathic urticaria (CIU) impairs quality of life (QoL). Currently, no consensus exists regarding how second\u2010generation H\n                    <jats:sub>1<\/jats:sub>\n                    \u2010antihistamines (proven to control CIU symptoms) should be taken long\u2010term: as daily treatment or only when symptoms return (PRN). We sought to determine which regimen improves or better maintains QoL in CIU: desloratadine (DL) daily or PRN.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:\u2002<\/jats:bold>\n                    Subjects with CIU initially responding to DL 5\u2003mg\/day for 4\u2003weeks were randomized for an additional 8\u2003weeks, to DL 5\u2003mg\/day (arm 1: \u2018continuous\u2019,\n                    <jats:italic>n<\/jats:italic>\n                    \u2003=\u200346) or to DL only on days when urticarial wheals were present (arm 2: \u201cPRN\u201d,\n                    <jats:italic>n<\/jats:italic>\n                    \u2003=\u200360). To ensure blinding, treatment was presented in both arms as a combination of daily treatment (arm 1: DL; arm 2: placebo), plus a \u201crescue\u201d tablet (arm 1: placebo; arm 2: DL) to be taken only in case of symptoms. The main outcome measure was QoL assessed by the VQ\u2010Dermato, a validated French QoL instrument, and the Dermatology Life Quality Index (DLQI).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:\u2002<\/jats:bold>\n                    At 4 and 8\u2003weeks after randomization, subjects taking continuous DL showed statistically significant improvements in VQ\u2010Dermato Global Index score (\n                    <jats:italic>P<\/jats:italic>\n                    \u2003=\u20030.001 and\n                    <jats:italic>P<\/jats:italic>\n                    \u2003=\u20030.016, respectively) and dimension scores for daily living activity, mood state, and social functioning\n                    <jats:italic>vs<\/jats:italic>\n                    subjects taking DL PRN. Improvement in DLQI score at Week 4 was also significantly greater with continuous DL (\n                    <jats:italic>P<\/jats:italic>\n                    \u2003=\u20030.001).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:\u2002<\/jats:bold>\n                    Continuous daily therapy with DL 5\u2003mg is a better regimen than PRN treatment to maintain or improve QoL in subjects with CIU.\n                  <\/jats:p>","DOI":"10.1111\/j.1398-9995.2008.01913.x","type":"journal-article","created":{"date-parts":[[2009,1,7]],"date-time":"2009-01-07T04:46:00Z","timestamp":1231303560000},"page":"605-612","source":"Crossref","is-referenced-by-count":69,"title":["How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily\n                    <i>vs<\/i>\n                    PRN and quality of life"],"prefix":"10.1111","volume":"64","author":[{"given":"J.\u2010J.","family":"Grob","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Auquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Dreyfus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.\u2010P.","family":"Ortonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,3,12]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506293322608"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2005.00964.x"},{"key":"e_1_2_7_4_2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archderm.1997.03890440085013","article-title":"The pathogenesis of chronic idiopathic urticaria","volume":"133","author":"Sabroe RA","year":"1997","journal-title":"Arch Dermatol"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200528120-00005"},{"key":"e_1_2_7_6_2","first-page":"96","article-title":"Quality of life in patients with urticaria","volume":"27","author":"Weldon DR","year":"2006","journal-title":"Allergy Asthma Proc"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1385\/CRIAI:30:1:047"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2005.00833.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1997.d01-1168.x"},{"key":"e_1_2_7_10_2","first-page":"137","volume-title":"Effectiveness and outcomes in health care: proceedings of an invitational conference by the Institute of Medicine","author":"Patrick DL","year":"1990"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2005.00962.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2003.00091.x"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1159\/000018250"},{"key":"e_1_2_7_14_2","first-page":"385","article-title":"Consensus conference: management of chronic urticaria. Wednesday 8 January 2003. Institut Pasteur\u2010Paris, France. Recommendations (short version)","volume":"13","author":"Soci\u00e9t\u00e9 Fran\u00e7aise de Dermatologie","year":"2003","journal-title":"Eur J Dermatol"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2001.00186.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.143"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200708010-00005"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02385.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)61466-4"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06385.x"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.113080"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-005-1368-3"},{"key":"e_1_2_7_23_2","first-page":"157","article-title":"The effect of fexofenadine hydrochloride on productivity and quality of life in patients with chronic idiopathic urticaria","volume":"79","author":"Spector SL","year":"2007","journal-title":"Cutis"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2004.02019.x"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2005.02609.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.07049.x"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.2008.01913.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1398-9995.2008.01913.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T20:38:36Z","timestamp":1697402316000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.2008.01913.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,12]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1111\/j.1398-9995.2008.01913.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.2008.01913.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1147106.619468","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1147106.604229","asserted-by":"object"}]},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,12]]}}}